Company Snapshot: EMIS  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Emisphere Technologies, Inc. Presentation at J.P. Morgan H & Q Annual Health Care Conference to Be Webcast

    TARRYTOWN, N.Y., Jan. 4 /PRNewswire/ --
Emisphere Technologies, Inc. (Nasdaq: EMIS) announced today that its corporate
presentation to the investment community for the J.P. Morgan H & Q 20th
Healthcare Conference will be webcast over the internet.  Chairman and Chief
Executive Officer, Michael M. Goldberg, M.D., will present on Monday,
January 7, 2002 at 11:00 a.m. Pacific Time from the Westin St. Francis Hotel
in San Francisco, California.
    Interested investors can access the audio portion of the presentation at
http://php4.eventsdigital.com/events/jpmhq/healthcare2002/index.html.  This
presentation will be broadcast live at 11:00 a.m. Pacific Time, and will be
archived for 90 days.  Please note, the corresponding slides will also be
posted for viewing on Emisphere's website at
http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=EMIS&script=1200 where
they will be archived for 30 days.

    Emisphere Technologies, Inc., is a biopharmaceutical company pioneering
the oral delivery of otherwise injectable or inhaled drugs.  By applying its
unique carrier technology, Emisphere has taken a leadership position in
solving the oral delivery of proteins, peptides and other macromolecules
produced by both pharmaceutical and biotechnology companies. Seven Emisphere
formulations have advanced into clinical trials being conducted by Emisphere
and its partners.  Emisphere develops pharmaceutical products for its own
portfolio and has several strategic alliances and ongoing feasibility studies
with many of the world's leading pharmaceutical and biotechnology companies,
including Novartis Pharma AG, Eli Lilly and Company, Regeneron
Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc.

       For additional information, please visit Emisphere's web site at
                              http://www.emisphere.com



SOURCE Emisphere Technologies, Inc.




Back to Topback to top

Related links:
  • http://www.emisphere.com
  • http://conference.hamquist.com/healthcare02
    CONTACT:
    Dory A. Lombardo-Valiquette, Investor
    Relations of Emisphere Technologies, Inc., +1-914-785-4742; or
    Investors - Jonathan M. Nugent, or Media - Ken Lewis,
    +1-212-213-0006, both of Burns McClellan for Emisphere
    Technologies